20
Jul 2026
Study links severe floods to higher opioid overdose deaths in rural Appalachia
Severe flooding may contribute to higher mortality rates from opioid use in rural Appalachia, according to a study by researchers at Penn State.

Neurosciences encompasses a broad range of research from the molecular (e.g. aptamer research) to clinical (e.g. research into concussion from sports).
Our goal is to be internationally recognized in 3 areas (neuro-oncology, dementia and neurodegeneration and molecular psychiatry). We have a bench to bedside approach capitalizing on our quite unique staff profile ranging from basic biomedical scientists through pharmaceutics to clinicians.
We also focus on collaborations with our local charities and a network of researchers and clinicians across the world.
We have a significant local impact in our neuro-oncology research. One strand of our Molecular Psychiatry group is research into legal highs and this research has had an impact on the government drug policy. Our Dementia and Neurodegeneration group is funded by the company.
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
20
Jul 2026
Severe flooding may contribute to higher mortality rates from opioid use in rural Appalachia, according to a study by researchers at Penn State.
20
Jul 2026
Texas Tech University faculty Peter Keyel and Kai Zhang are teaming up to build foundational knowledge concerning leishmaniasis, a common, but neglected protozoan parasitic disease.
20
Jul 2026
Despite growing evidence that GLP-1 medications improve health and are worth their cost, many insurance plans still limit coverage. University of Mississippi researchers are examining why, and where that leaves patients.
20
Jul 2026
In 2023, nearly 51 million people were injured and 1.34 million died from road injuries, making road injuries one of the leading global causes of premature death and disability, according to a new study published today in The Lancet Public Health.